- Tel: 858.663.9055
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Cytokine Antibodies target a broad class of small, secreted proteins that regulate immune communication, inflammation, and tissue homeostasis. Cytokines are produced by immune cells, stromal cells, and epithelial cells in response to infection, injury, or environmental stress. They act as messengers, shaping innate and adaptive immune responses through paracrine and autocrine signaling.
Key cytokine families include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), chemokines, and colony-stimulating factors (CSFs). Each plays a distinct role in immune regulation, from promoting T-cell differentiation to orchestrating leukocyte recruitment and controlling antiviral defenses. Because cytokine imbalances contribute to autoimmunity, chronic inflammation, infectious disease, and cancer, the Cytokine Antibodies portfolio provides critical tools for studying their biology and clinical significance.
NSJ Bioreagents supplies Cytokine Antibodies validated for immunohistochemistry, flow cytometry, ELISA, immunofluorescence, and western blotting. Each Cytokine Antibody undergoes rigorous validation to ensure high sensitivity and specificity, even when cytokines are expressed at low levels.
By selecting Cytokine Antibodies from NSJ Bioreagents, researchers gain reagents optimized for reproducibility and performance across multiple platforms. Our antibodies provide strong signal detection, minimal background, and reliable results in complex biological systems. With detailed datasheets, suggested controls, and validated protocols, NSJ Bioreagents supports reproducible outcomes in immunology and translational medicine.
The Cytokine Antibodies collection is used across a wide spectrum of research and clinical contexts.
Cytokine Antibodies clarify signaling pathways that shape innate and adaptive immunity.
These antibodies detect cytokines driving T-cell activation, differentiation, and memory formation.
Cytokine Antibodies support studies of immune tolerance and autoimmunity.
Cytokine Antibodies measure IL-1, IL-6, TNF-α, and other mediators of inflammation.
These reagents support research into chronic diseases such as rheumatoid arthritis and lupus.
Cytokine Antibodies validate biomarkers used to assess disease activity and treatment response.
Cytokine Antibodies detect interferons and chemokines central to antiviral and antibacterial defense.
These reagents help map cytokine storms in viral infections such as influenza or COVID-19.
Cytokine Antibodies are applied in translational research on vaccines and immune-based therapies.
Cytokine Antibodies highlight tumor-associated cytokines that promote growth or immune evasion.
These reagents support biomarker studies in immunotherapy trials.
Cytokine Antibodies clarify how cytokine networks shape the tumor microenvironment.
Cytokine Antibodies detect IL-4, IL-5, and IL-13 in allergic inflammation.
These reagents support studies of asthma, atopic dermatitis, and food allergies.
Cytokine Antibodies monitor CSFs and growth factors that regulate hematopoietic and mesenchymal stem cells.
These reagents validate differentiation pathways in regenerative medicine models.
Cytokine Antibodies are used in biomarker discovery for diagnostics and personalized medicine.
These reagents support patient stratification in clinical trials of biologic therapies targeting cytokines.
Cytokine Antibodies provide tools for evaluating treatment efficacy and monitoring immune modulation.
Cytokines coordinate immune and inflammatory responses, and the Cytokine Antibodies portfolio provides researchers with precise tools for detecting them in health and disease.
In basic immunology, Cytokine Antibodies clarify how signaling networks govern immune responses. In inflammatory disease research, they provide insight into cytokine dysregulation. In oncology, Cytokine Antibodies highlight tumor–immune interactions, while in infectious disease, they help uncover protective and pathological immune responses.
Clinically, cytokines are therapeutic targets for biologics such as monoclonal antibodies against TNF-α, IL-6, and IL-17. Reliable detection with Cytokine Antibodies ensures accurate biomarker monitoring, drug development, and therapeutic evaluation.
Cytokines are master regulators of immunity, inflammation, and disease. The Cytokine Antibodies portfolio equips researchers and clinicians with validated reagents for detecting these key molecules across immunology, oncology, infectious disease, and translational medicine. By ensuring reproducibility and specificity, Cytokine Antibodies remain indispensable tools for advancing biomedical discovery and improving patient outcomes.
IHC staining of FFPE human adrenal gland tissue with IL-2 antibody (clone IL2/9007, cat # V5371). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA for 20 min and allow to cool before testing.
| ||
![]() |
| ||
![]() |